Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Slow Release Oral Milrinone in Advanced Heart Failure
NCT01956006Phase 2Completed
- Sponsor
- Alfred Health
- Start
- Oct 2013
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of milrinone in heart failure (HF), sponsored by Alfred Health. Started Oct 2013; status: completed.
02
Drugs
milrinone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01956006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01956006.